Pages that link to "Q28251326"
Jump to navigation
Jump to search
The following pages link to Identification and characterization of cellular receptors for the growth regulator, oncostatin M (Q28251326):
Displaying 11 items.
- Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6 (Q24337530) (← links)
- Cleavage of a hydrophilic C-terminal domain increases growth-inhibitory activity of oncostatin M (Q24600562) (← links)
- Molecular cloning, sequence analysis, and functional expression of a novel growth regulator, oncostatin M (Q24633689) (← links)
- AIDS-associated Kaposi's sarcoma (KS) cells express oncostatin M (OM)-specific receptor but not leukemia inhibitory factor/OM receptor or interleukin-6 receptor. Complete block of OM-induced KS cell growth and OM binding by anti-gp130 antibodies (Q24678972) (← links)
- Oncostatin M binds to extracellular matrix in a bioactive conformation: implications for inflammation and metastasis (Q35084743) (← links)
- Oncostatin M is a mitogen for rabbit vascular smooth muscle cells (Q36076266) (← links)
- Oncostatin M is a proinflammatory mediator. In vivo effects correlate with endothelial cell expression of inflammatory cytokines and adhesion molecules (Q37369789) (← links)
- Evaluation and optimization of hepatocyte culture media factors by design of experiments (DoE) methodology (Q39918228) (← links)
- A computer simulation approach to assessing therapeutic intervention points for the prevention of cytokine-induced cartilage breakdown (Q39937956) (← links)
- Oncostatin-M stimulates tyrosine protein phosphorylation in parallel with the activation of p42MAPK/ERK-2 in Kaposi's cells. Evidence that this pathway is important in Kaposi cell growth (Q40339285) (← links)
- Molecular Profiling of Ulcerative Colitis Subjects from the TURANDOT Trial Reveals Novel Pharmacodynamic/Efficacy Biomarkers (Q64285341) (← links)